Paul Fairchild

Director, 21st Century School, Stem Cell Institute, University of Oxford

Degree (Hons) in Biological Sciences; DPhil, Nuffield Department of Surgery, focussing on immune response to organ allografts; five years with Department of Pathology, University of Cambridge. With University of Oxford: currently, Lecturer, Sir William Dunn School of Pathology and Co-Director, Oxford Stem Cell Institute; has applied his immunological training to emerging field of cell replacement therapy and regenerative medicine to investigate immune response to tissues differentiated from embryonic stem cells, the rejection of which threatens to undermine success of regenerative medicine in the future; has developed strategies which may one day promote indefinite survival of stem cell-derived grafts and is currently collaborating with biotechnology sector to bring such technologies to clinic.

关于我们

  • 我们的任务
  • 我们的历史
  • 领导团队
  • 影响力

加入我们

快捷链接

语言版本

隐私政策和服务条款

站点地图

© 2025 世界经济论坛